Great West Life Assurance Co. Can lifted its position in shares of Steris PLC (NYSE:STE) by 8.7% in the first quarter, Holdings Channel reports. The institutional investor owned 134,537 shares of the medical equipment provider’s stock after acquiring an additional 10,815 shares during the quarter. Great West Life Assurance Co. Can’s holdings in Steris were worth $17,174,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. increased its holdings in shares of Steris by 10.3% during the 4th quarter. BlackRock Inc. now owns 8,549,361 shares of the medical equipment provider’s stock worth $913,498,000 after buying an additional 800,900 shares during the last quarter. Vanguard Group Inc increased its holdings in Steris by 1.8% in the 3rd quarter. Vanguard Group Inc now owns 7,516,051 shares of the medical equipment provider’s stock valued at $859,837,000 after purchasing an additional 133,510 shares during the last quarter. Oregon Public Employees Retirement Fund increased its holdings in Steris by 10,585.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 3,539,306 shares during the last quarter. WCM Investment Management LLC increased its holdings in Steris by 3.8% in the 4th quarter. WCM Investment Management LLC now owns 2,364,222 shares of the medical equipment provider’s stock valued at $252,617,000 after purchasing an additional 85,819 shares during the last quarter. Finally, Westfield Capital Management Co. LP increased its holdings in Steris by 55.1% in the 4th quarter. Westfield Capital Management Co. LP now owns 958,036 shares of the medical equipment provider’s stock valued at $102,366,000 after purchasing an additional 340,204 shares during the last quarter. Institutional investors and hedge funds own 83.36% of the company’s stock.
Several research firms recently weighed in on STE. JMP Securities lifted their target price on shares of Steris from $135.00 to $150.00 and gave the company a “market outperform” rating in a report on Wednesday, May 22nd. Stephens lifted their target price on shares of Steris from $135.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, May 15th. KeyCorp lifted their target price on shares of Steris from $135.00 to $138.00 and gave the company an “overweight” rating in a report on Wednesday, May 15th. Finally, Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $146.00 target price for the company in a report on Tuesday, April 30th. Five equities research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average target price of $148.20.
Steris (NYSE:STE) last posted its earnings results on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.44 by $0.09. Steris had a net margin of 10.93% and a return on equity of 13.34%. The firm had revenue of $768.00 million during the quarter, compared to the consensus estimate of $738.87 million. During the same quarter last year, the firm earned $1.24 EPS. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, sell-side analysts expect that Steris PLC will post 5.38 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Wednesday, June 12th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, June 11th. This represents a $1.36 annualized dividend and a yield of 1.01%. Steris’s dividend payout ratio (DPR) is presently 27.81%.
In other Steris news, CEO Walter M. Rosebrough, Jr. sold 50,000 shares of the business’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $125.00, for a total value of $6,250,000.00. Following the completion of the transaction, the chief executive officer now owns 98,895 shares in the company, valued at $12,361,875. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Mohsen Sohi sold 3,133 shares of the business’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $135.94, for a total transaction of $425,900.02. The disclosure for this sale can be found here. Insiders sold a total of 60,351 shares of company stock valued at $7,592,622 in the last quarter. 2.38% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: This story was reported by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/4354138/steris-plc-ste-stake-increased-by-great-west-life-assurance-co-can.html.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: Bid-Ask Spread
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.